Kahweol

Kahweol is a diterpene found naturally in unfiltered coffee oils that exerts anticancer and anti-inflammatory effects primarily by modulating apoptotic pathways, including downregulation of Bcl-2 and Mcl-1 anti-apoptotic proteins. It also demonstrates gastroprotective and analgesic properties in preclinical models, making it one of coffee's most pharmacologically active minor constituents.

Origin & History

Kahweol is a diterpene specific to coffee, predominantly found in the beans of Coffea arabica. It is naturally extracted during coffee brewing, with higher concentrations in unfiltered coffee compared to filtered varieties.

Historical & Cultural Context

There are no documented traditional or historical uses for kahweol. Its identification as a bioactive compound is a result of modern scientific research, primarily due to its presence in coffee.

Health Benefits

• Inhibits prostate tumor growth via apoptosis induction in animal models (PMID: 30569541). • Provides gastroprotection and anti-H. pylori activity in mice (PMID: 41634338). • Induces apoptosis in various cancer cells by down-regulating anti-apoptotic proteins. • Shows potential peripheral antinociceptive effects in rats through CB1 receptor activation. • Synergizes with cafestol to reduce prostate cancer cell proliferation.

How It Works

Kahweol induces apoptosis in cancer cells by downregulating anti-apoptotic proteins Bcl-2 and Mcl-1 while activating caspase-3 and caspase-9, shifting the balance toward programmed cell death. It inhibits the NF-κB signaling pathway, reducing transcription of pro-inflammatory cytokines such as TNF-α and IL-6. Additionally, kahweol modulates phase II detoxification enzymes, including glutathione S-transferase, contributing to its chemoprotective and gastroprotective effects.

Scientific Research

No human clinical trials or meta-analyses have been conducted on kahweol. Current evidence is based on in vitro and in vivo animal studies, such as the rat xenograft model for prostate cancer (PMID: 30569541) and a mouse model for gastric ulcers (PMID: 41634338).

Clinical Summary

The majority of evidence for kahweol comes from in vitro cell studies and rodent animal models rather than human clinical trials, which limits the strength of conclusions. In a mouse model of prostate cancer (PMID: 30569541), kahweol administration significantly inhibited tumor growth via apoptosis induction, though specific dosages and tumor size reductions were not standardized across studies. Gastroprotective effects against H. pylori were demonstrated in murine models (PMID: 41634338), suggesting mucosal defense mechanisms, but no controlled human trials have confirmed these outcomes. Peripheral antinociceptive effects have also been observed in animal pain models, indicating analgesic potential that remains unvalidated in humans.

Nutritional Profile

Kahweol is a diterpene molecule (C20H28O3, MW ~316.43 g/mol) of the kaurane family, found exclusively in the lipid fraction of coffee beans (Coffea arabica). It is not a macronutrient or micronutrient itself but rather a bioactive compound. Key details: • Concentration in coffee: Kahweol exists primarily as kahweol palmitate (fatty acid ester) in coffee oil; unfiltered/boiled coffee contains approximately 2–6 mg kahweol per 150 mL cup, while paper-filtered coffee contains negligible amounts (<0.1 mg/cup) as the filter removes most of the lipid fraction. • Espresso provides an intermediate level (~1–4 mg per serving). • Coffee oil (lipid fraction of green beans) contains roughly 2–9 mg/g kahweol esters depending on variety and roasting. • Typically co-occurs with cafestol (a structurally related diterpene) in an approximate 1:1 to 1:1.5 kahweol-to-cafestol ratio; the two compounds frequently exhibit synergistic biological effects. • Roasting degrades kahweol significantly; darker roasts contain substantially lower concentrations than light or medium roasts; dehydrokahweol and other oxidation products may form. • Bioavailability: Kahweol esters are hydrolyzed in the small intestine by lipases to release free kahweol. Absorption occurs in the gastrointestinal tract; however, quantitative oral bioavailability data in humans is limited. Animal studies suggest moderate absorption with hepatic first-pass metabolism. Kahweol and cafestol are known to modulate phase I (CYP enzymes) and phase II (glutathione S-transferase, UDP-glucuronosyltransferase) detoxification enzymes, which may influence the metabolism of co-ingested compounds. • No significant vitamin, mineral, fiber, or protein content—kahweol is a lipophilic small molecule, not a food matrix. • Solubility: Poorly water-soluble; present in the oily fraction of coffee and best extracted with organic solvents or retained in unfiltered brewing methods (French press, Turkish coffee, Scandinavian boiled coffee). • Caloric contribution is negligible at dietary intake levels.

Preparation & Dosage

Preclinical dosages include oral doses up to 10 mg/kg for gastroprotection in mice and local injections of 40-80 µg for antinociception in rats. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Cafestol, Curcumin, Resveratrol, Green tea extract, Omega-3 fatty acids

Safety & Interactions

Kahweol, like other coffee diterpenes including cafestol, raises serum LDL cholesterol levels when consumed in unfiltered coffee such as French press or espresso, representing a cardiovascular concern with habitual high intake. Individuals with hyperlipidemia or existing cardiovascular disease should exercise caution with unfiltered coffee consumption, as paper filters effectively remove most diterpenes including kahweol. No formal drug interaction studies exist for isolated kahweol supplements, but theoretical interactions with cytochrome P450 enzymes and anticoagulant medications like warfarin cannot be excluded given its enzyme-modulating activity. Pregnancy safety for isolated kahweol supplementation has not been established, and it should be avoided in pregnant or breastfeeding individuals until human safety data are available.